Seroquel Off-Label Settlement Puts Clinical Researchers In Spotlight
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca has an agreement in principle to resolve government investigation of its antipsychotic promotion and pay $520 million.